Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): Experience in 200 tumours

BJU International

Volumn 113, Issue 3, 2014, Pages 416-428

  Wah, Tze M ^a   Irving, Henry C ^a   Gregory, Walter ^b   Cartledge, Jon ^a   Joyce, Adrian D ^a   Selby, Peter J ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

complication; radiofrequency ablation; renal cell carcinoma; survival rates

Indexed keywords

ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; BLEEDING; BONE METASTASIS; CALYCEAL CUTANEOUS FISTULA; CANCER GRADING; CANCER SURVIVAL; COLD PYELOPERFUSION TECHNIQUE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDRODISSECTION TECHNIQUE; KIDNEY ABSCESS; KIDNEY BIOPSY; KIDNEY CARCINOMA; KIDNEY FAILURE; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SKIN FISTULA; SURGICAL APPROACH; SURGICAL TECHNIQUE; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; URETER INJURY; URETER STRICTURE; VERY ELDERLY;

COMPLICATION; RADIOFREQUENCY ABLATION; RENAL CELL CARCINOMA; SURVIVAL RATES;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CATHETER ABLATION; CONSTRICTION, PATHOLOGIC; CUTANEOUS FISTULA; DISSECTION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPOTHERMIA, INDUCED; KIDNEY NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM, RESIDUAL; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; URETERAL DISEASES; URINARY FISTULA; YOUNG ADULT;

EID: 84896709865     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12349     Document Type: Article

References (54)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004; 54: 8-29 (Pubitemid 38443417)
2. Office for National Statistics. Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2008, England. London: Office for National Statistics, National Statistics, 2010
3. Globocan, 2008
4. Zagoria RJ,. Imaging of small renal masses: a medical success story. AJR Am J Roentgenol 2000; 175: 945-955
5. Jayson M, Sanders H,. Increased incidence of serendipitously discovered renal cell carcinoma. Urology 1998; 51: 203-205 (Pubitemid 28093168)
6. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK,. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst 2006; 98: 1331-1334 (Pubitemid 44530728)
7. Nguyen MM, Gill IS, Ellison LM,. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. J Urol 2006; 176: 2397-2400 (Pubitemid 44755062)
8. Pantuck AJ, Zisman A, Belldegrun AS,. The changing natural history of renal cell carcinoma. J Urol 2001; 166: 1611-1623
9. Pantuck AJ, Zisman A, Rauch MK, Belldegrun A,. Incidental renal tumors. Urology 2000; 56: 190-196 (Pubitemid 30495565)
10. Luciani LG, Cestari R, Tallarigo C,. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997). Urology 2000; 56: 58-62 (Pubitemid 30408654)
11. Remzi M, Marberger M,. Renal tumor biopsies for evaluation of small renal tumors: why, in whom, and how? Eur Urol 2009; 55: 359-367
12. Abouassaly R, Lane BR, Novick AC,. Active surveillance of renal masses in elderly patients. J Urol 2008; 180: 505-509
13. Ljungberg B, Cowan NC, Hanbury DC, et al. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58: 398-406
14. Huang WC, Levey AS, Serio AM, et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 2006; 7: 735-740 (Pubitemid 44283660)
15. Van Poppel H, Becker F, Cadeddu JA, et al. Treatment of localised renal cell carcinoma. Eur Urol 2011; 60: 662-672
16. Uzzo RG, Novick AC,. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001; 166: 6-18 (Pubitemid 32565331)
17. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV,. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75-80 (Pubitemid 350216747)
18. Hafez KS, Novick AC, Butler BP,. Management of small solitary unilateral renal cell carcinomas: impact of central versus peripheral tumor location. J Urol 1998; 159: 1156-1160 (Pubitemid 28172784)
19. Thompson RH,. Radical nephrectomy: too radical for small renal masses? Lancet 2006; 368: 823-824 (Pubitemid 44292815)
20. Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA,. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years. Cancer 2010; 116: 3135-3142
21. Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR,. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology 2011; 77: 1393-1397
22. Duffey B, Nguyen V, Lund E, Koopmeiners JS, Hulbert J, Anderson JK,. Intermediate-term outcomes after renal cryoablation: results of a multi-institutional study. J Endourol 2012; 26: 15-20
23. Zagoria RJ,. Percutaneous image-guided radiofrequency ablation of renal malignancies. Radiol Clin North Am 2003; 41: 1067-1075 (Pubitemid 37152092)
24. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR,. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 417-424 (Pubitemid 36313429)
25. Mayo-Smith WW, Dupuy DE, Parikh PM, Pezzullo JA, Cronan JJ,. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 2003; 180: 1503-1508 (Pubitemid 36687077)
26. Silverman SG, Lee BY, Seltzer SE, Bloom DA, Corless CL, Adams DF,. Small (< or = 3 cm) renal masses: correlation of spiral CT features and pathologic findings. AJR Am J Roentgenol 1994; 163: 597-605 (Pubitemid 24294368)
27. Ho VB, Allen SF, Hood MN, Choyke PL,. Renal masses: quantitative assessment of enhancement with dynamic MR imaging. Radiology 2002; 224: 695-700 (Pubitemid 34919800)
28. Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR,. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217: 665-672
29. Breen DJ, Rutherford EE, Stedman B, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Intervent Radiol 2007; 30: 936-942 (Pubitemid 47497860)
30. Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol 2008; 19: 1034-1040
31. Wah TM, Koenig P, Irving HC, et al. Radiofrequency ablation of a central renal tumor: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol 2005; 16: 1551-1555 (Pubitemid 43017704)
32. Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML,. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. AJR Am J Roentgenol 2003; 181: 1315-1317 (Pubitemid 37296409)
33. Wile GE, Leyendecker JR, Krehbiel KA, Dyer RB, Zagoria RJ,. CT and MR imaging after imaging-guided thermal ablation of renal neoplasms. Radiographics 2007; 27: 325-340
34. Wah TM, Irving HC,. Infectious complications after percutaneous radiofrequency ablation of renal cell carcinoma in patients with ileal conduit. J Vasc Interv Radiol 2008; 19: 1382-1385
35. Wah TM, Irving HC,. Acute tubular necrosis following radiofrequency ablation of a renal cell carcinoma. Cardiovasc Intervent Radiol 2009; 32: 591-592
36. McDougal WS, Gervais DA, McGovern FJ, Mueller PR,. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005; 174: 61-63 (Pubitemid 40825672)
37. Levinson AW, Su LM, Agarwal D, et al. Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass. J Urol 2008; 180: 499-504
38. Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA,. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63: 486-492
39. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR,. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185: 64-71
40. Matsumoto ED, Johnson DB, Ogan K, et al. Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors. Urology 2005; 65: 877-881 (Pubitemid 40692974)
41. Poon RT, Ng KK, Lam CM, et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004; 239: 441-449 (Pubitemid 38372759)
42. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE,. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 2007; 189: 429-436 (Pubitemid 47195930)
43. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR,. Radiofrequency ablation of renal cell carcinoma: part 2, Lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 2005; 185: 72-80
44. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY,. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
45. Wehrenberg-Klee E, Clark TW, Malkowicz SB, et al. Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol 2012; 23: 41-45
46. Prevoo W, van den Munckhof MP, Meinhardt W, Horenblas S, van den Bosch MA,. Radiofrequency ablation of kidney tumours in patients with a solitary kidney. Clin Radiol 2010; 65: 230-236
47. Raman JD, Raj GV, Lucas SM, et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int 2009; 105: 496-500
48. Gervais DA,. Preexisting chronic kidney disease and renal tumor ablation: preliminary answers and persistent questions. J Vasc Interv Radiol 2012; 23: 46-47
49. Aron M, Kamoi K, Haber GP, et al. Laparoscopic renal cryoablation: long-term oncologic outcomes with minimum 5 year follow up. J Urol 2008; 179 (Suppl.): 209-210
50. Kunkle DA, Uzzo RG,. Cryoablation or radiofrequency ablation of the small renal mass: a meta-analysis. Cancer 2008; 113: 2671-2680
51. Lane BR, Gill IS,. 7-year oncological outcomes after laparoscopic and open partial nephrectomy. J Urol 2010; 183: 473-479
52. Yossepowitch O, Bjartell A, Eastham JA, et al. Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 2008; 179: 2158-2163
53. Kutikov A, Uzzo RG,. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 2009; 182: 844-853
54. Ficarra V, Novara G, Secco S, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol 2009; 56: 786-793